Showing results (101-110 of 505) with videos related to
Sort By:
Pageof 51
Journal of Clinical Pharmacology|September 1, 1986
Phase I and II agents in cancer therapy: I. Anthracyclines and related compoundsS Wadler, J Z Fuks, P H WiernikMedical and Pediatric Oncology|January 1, 1982
Restaging laparotomy in the management of the non-Hodgkin lymphomasJ Z Fuks, J Aisner, P H WiernikCancer|July 15, 1982
Hydrocele following treatment for Hodgkin's diseaseP Duffey, E W Campbell, P H WiernikAmerican Journal of Therapeutics|May 1, 1997
A review of the clinical experience with irinotecan (CPT-11)R W Horowitz, S Wadler, P H WiernikThe New England Journal of Medicine|July 6, 1978
Frozen autologous platelet transfusion for patients with leukemiaC A Schiffer, J Aisner, P H WiernikArchives of Physical Medicine and Rehabilitation|June 1, 1980
Peripheral neuropathy after cis-platinum (II) (DDP) therapyL Reinstein, S S Ostrow, P H WiernikCancer Treatment Reports|March 1, 1981
Doxorubicin and dactinomycin therapy for advanced sarcomasD E Brenner, P Chang, P H WiernikJournal of Clinical Pharmacology|May 1, 1987
Phase I and II agents in cancer therapy: two cisplatin analogues and high-dose cisplatin in hypertonic saline or with thiosulfate protectionJ Z Fuks, S Wadler, P H WiernikThe American Journal of Medicine|December 1, 1980
Staphylococcus aureus bacteremia in patients with acute leukemiaS B Sotman, S C Schimpff, V M YoungClinical and Experimental Dermatology|June 15, 2005
Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literatureD T Alexandrescu, L Koulova, P H WiernikPageof 51